|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
SAPA-GP is the largest professional organization of China-heritaged pharmaceutical professionals in the Greater Philadelphia area.
For over ten years, we strive to serve the community of pharmaceutical professionals by promoting advance of pharmaceutical sciences, building scientific and business connections between US and China, and fostering career and personal growth of professional members.
SAPA-GP Annual Conference is the most respected and well attended regional meeting for pharmaceutical professionals who are interested in scientific and business issues related to both US and China bio-pharmaceutical industry. We are particuarlly excited to announce that University of Pennsylvania joined force with SAPA-GP this year as a conference co-organizer. This year's conference theme builds on a key global industrial trend:
"Paradigm Shift in Pharma ? Interplay Between China and U.S."
During the event, participants will be joined by senior executives from multinational pharmaceutical firms, scholars from academic institutions, and FDA officials. You will hear invited speakers to share their unique insights on broad range of topics:
* Collaborations with China
* Continuous Transformation of U.S. Pharma Industry
* Beyond Emerging and Rising of China Pharma Industry
* Role of Venture Capital and Business Opportunities
Some of the confirmed speakers include:
Mr. Lawton R. Burns, Prof. of Health Care Management, the Wharton School
Dr. Jeremy Caldwell, VP, Screening and Protein Sciences, Merck
Dr. Greg Guyer, SVP, Global Quality, Merck.
Dr. John Hubbard, SVP & Worldwide Head, Development Operations, Pfizer
Dr. Olivier Jarry, VP, Head of Emerging Markets Strategy & Operations, BMS
Dr. Sandy Macrae, SVP, Emerging Markets R&D, GlaxoSmithKline
Dr. Jeffrey S. Nye, VP, Global Head External Innovation, Neuroscience, J&J
Dr. Richard Soll, SVP, Corporate Aliance, Wuxi Apptech
Dr. John S. Swartley, Deputy Exe. Director of the Center for technology Transfer, the Univ. of Pennsylvania
Dr. Yaning Wang, Asso. Dir., Office of Clinical Pharmacology, CDER, FDA
Dr. Yinxiang Wang, CEO, Zhejiang Beta Pharma
Mr. Jack Xu, Deputy Director, Shanghai Clinical Research Center
Dr. Dayao Zhao, Head of China R&D, J&J
Dr. Liang Zhao, Senior reviewer, CDER, FDA
The conference will be held on June 22nd and 23rd on the beautiful campus of Villanova University.
The conference program is attached and will be updated at http://www.sapa-gp.org/2012/SAPA-GP_2012_Annual_Conference.pdf
To register or raise questions about the 10th SAPA-GP Annual Conference, please go to http://www.sapa-gp.org/
Office of Research Program Development (RPD)
Office of the Executive Vice Dean and Chief Scientific Officer
presents
Research Symposium
"Funding the Transition: Making the Move from Individual Research to the Team Science Approach"
Friday, June 22, 2012
9 to 12 pm
For more information contact RPD
215-898-0132
BUILDING RESEARCH BRIDGES AROUND THE WORLD
Pittsburgh, PA
June 22, 2012
The Office for Human Research Protections (OHRP), University of Pittsburgh, Carnegie Mellon University, and VA Pittsburgh Healthcare System are co-sponsoring an OHRP Research Community Forum (RCF) entitled, “BUILDING BRIDGES: Research Around the World,” at the Sheraton Station Square Hotel in Pittsburgh, PA on June 22, 2012.
This program is quite innovative in the sense that this is the first program in the OHRP RCF series to focus solely on international research. A group of nationally and internationally-recognized experts will address the regulatory and ethical underpinnings of conducting research with human subjects in international settings. Our goal is to raise awareness of diverse global interests and to strengthen collaborations between US investigators and those abroad.
The dynamic multi-faceted agenda will provide a Keynote Address, 4 Breakout Sessions, 13 Breakout Sessions, and a Panel Discussion, as follows:
Keynote Address: Ethical Challenges in Collaborative International Research Presented by Christine Grady, R.N., Ph.D., Chief, Department of Bioethics, National Institutes of Health, Clinical Center; Member of President Obama’s Commission for the Study of Bioethical Issues; and Senior Fellow, Kennedy Institute of Ethics
4 Plenary Sessions:
• Conducting FDA-Regulated Research in an Exceptional World
• Ethics Committee Review of International Research
• Multicultural and Multidisciplinary Perspectives on the Consent Processes
• Tissue Banking – Domestic and International Challenges
13 Breakout Sessions
• International Export
• Lessons Learned from 25 Years of International Studies – Research Team Perspectives
• Tips and Tools for Planning Safe Travel
• Nuts and Bolts 45 CFR 46
• CDER OSI Perspective: Oversight of Foreign Clinical Trials
• Opportunities & Challenges: Computing Technology for International Research on Subjects
• Ensuring Regulatory Compliance at International Sites
• Research Ethics Training: International Perspectives
• Challenges in Negotiating Appropriate Subcontracts for Human Subjects Research Abroad
Panel Discussion
Updates and Questions and Answers with the Feds and Faculty
See Brochure at: